In Reply:
We thank Kinoshita et al. for their valuable comments on our article regarding helium preconditioning in human endothelium. 1 Kinoshita et al. state that there still remain questions regarding the underlying mechanism of the observed endothelial protection after helium-induced late and early preconditioning. In our experiments, 1 we have shown significant endothelial dysfunction after 20 min of forearm ischemia induced by inflating a blood pressure cuff. This endothelial dysfunction was prevented by helium early and late preconditioning. The experiments using the nonselective nitric oxide synthase inhibitor, NGmonomethyl-l-arginine, during helium preconditioning were performed to investigate whether endothelial nitric oxide synthase is crucially involved in the mechanism of the observed helium preconditioning. Because co-infusion of NG-monomethyl-l-arginine did not block the protective effect of helium, we concluded that endothelial nitric oxide synthase is not a central mediator of helium-induced preconditioning in this model. In contrast to the reference 2 cited by Kinoshita et al., we did not use NG-monomethyll-arginine as vasoconstrictive agent during acetylcholine infusion. Therefore, it is correct that we cannot conclude that nitric oxide derived from endothelium is the source of the acetylcholine-induced vasodilatory effect. The dosage of NG-monomethyl-l-arginine, we used equates to that, maximally reduces basal forearm blood flow in healthy volunteers without a possible systemic effect. 3 Unfortunately, we were unable to directly obtain endothelial cells from our volunteers to measure oxidative stress in those cells. The last comment raised by the authors pertained to reactive
